Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
when do you treat suspected autoimmune encephalitis before antibody results?
Related Questions
How does your decision to use high-efficacy disease-modifying treatments (HET) differ, if at all, when treating late-onset relapsing-remitting multiple sclerosis?
How does lack of success of rituximab treatment affect your decision to trial anti-CD19 therapies like inebilizumab?
What biomarkers best predict the response to B-cell depleting therapies in MS?
In a patient with prior biopsy-proven IgG4-related pachymeningitis who develops recurrent neurologic symptoms years after discontinuing immunosuppression, how do you determine whether this represents relapse versus alternative etiologies?
How do you monitor patients with transverse myelitis after a negative initial work up?
When should MOG-Ab be tested in patients with suspected autoimmune encephalitis with seizures and normal MRI?
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
When would you use ofatumumab for anti-NMDAR autoimmune encephalitis?
What are your vaccine recommendations while patients are on biologics?
